Ascendis Pharma A/S Adjusted Weighted Average Shares
Ascendis Pharma A/S (ASND) reported Adjusted Weighted Average Shares of 63.91 million shares for the 3-month period ending 2025-06-30, per its 6-K filed 2025-08-07.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:AdjustedWeightedAverageShares · last filed 2025-08-07
- Ascendis Pharma A/S adjusted weighted average shares for the quarter ending 2025-06-30 was 63.91M shares, a 5.11% increase year-over-year.
- Ascendis Pharma A/S adjusted weighted average shares for the quarter ending 2024-06-30 was 60.80M shares.
- Ascendis Pharma A/S adjusted weighted average shares for the quarter ending 2018-06-30 was 41.65M shares, a 28.15% increase year-over-year.
- Ascendis Pharma A/S adjusted weighted average shares for the quarter ending 2017-06-30 was 32.50M shares.
| Period end | Adjusted Weighted Average Shares 3 month | Adjusted Weighted Average Shares 6 month | Adjusted Weighted Average Shares 12 month |
|---|---|---|---|
| 2025-06-30 | 63.91M shares 6-K · filed 2025-08-07 | 60.24M shares 6-K · filed 2025-08-07 | |
| 2024-06-30 | 60.80M shares 6-K · filed 2025-08-07 | 57.11M shares 6-K · filed 2025-08-07 | |
| 2018-06-30 | 41.65M shares 6-K · filed 2018-08-29 | 40.18M shares 6-K · filed 2018-08-29 | |
| 2017-12-31 | 33.63M shares 20-F · filed 2018-03-28 | ||
| 2017-06-30 | 32.50M shares 6-K · filed 2018-08-29 | 32.47M shares 6-K · filed 2018-08-29 | |
| 2016-12-31 | 26.56M shares 20-F · filed 2018-03-28 | ||
| 2015-12-31 | 23.77M shares 20-F · filed 2018-03-28 |